Overexpression of tissue inhibitor of metalloproteinase-1 gene correlates with poor outcomes in colorectal cancer

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 4127-4130

  Inagaki, Daisuke ^a   Oshima, Takashi ^a   Yoshihara, Kazue ^b   Tamura, Shuzo ^b   Kanazawa, Amane ^b   Yamada, Takanobu ^b   Yamamoto, Naoto ^b   Sato, Tsutomu ^c   Shiozawa, Manabu ^b   Morinaga, Soichiro ^b   Akaike, Makoto ^b   Fujii, Shoichi ^a   Numata, Kazushi ^a   Kunisaki, Chikara ^a   Rino, Yasushi ^c   Tanaka, Katsuaki ^a   Masuda, Munetaka ^c   Imada, Toshio ^c  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Prognostic factor; TIMP 1

Indexed keywords

MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CANCER GENETICS; CANCER TISSUE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

COLORECTAL NEOPLASMS; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR MICROENVIRONMENT;

EID: 78650242500     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kotake K, Honjo S, Sugihara K, Kato T, Kodaira S, Takahashi T, Yasutomi M, Muto T and Koyama Y: Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46: S32-43, 2003.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
3. Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89: 1260-1270, 1997. (Pubitemid 27371946)
4. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6: 121-125, 1990. (Pubitemid 20105600)
5. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET and Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59: 329-341, 1993. (Pubitemid 23344435)
6. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T and Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 53: 1397-1402, 1993.
7. Akahane T, Akahane M, Shah A, Connor CM and Thorgeirsson UP: TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res 301: 158-167, 2004. (Pubitemid 39504969)
8. Liu XW, Bernardo MM, Fridman R and Kim HR: Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 278: 40364-40372, 2003. (Pubitemid 37248605)
9. Asano T, Tada M, Cheng S, Takemoto N, Kuramae T, Abe M, Takahashi O, Miyamoto M, Hamada J, Moriuchi T and Kondo S: Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. J Surg Res 146: 32-42, 2008. (Pubitemid 351442927)
10. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM and Fodstad O: High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 3: 1623-1628, 1997.
11. Davidsen ML, Wurtz SO, Romer MU, Sorensen NM, Johansen SK, Christensen IJ, Larsen JK, Offenberg H, Brunner N and Lademann U: TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis. Br J Cancer 95: 1114-1120, 2006.
12. Baker EA, Bergin FG and Leaper DJ: Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 87: 1215-1221, 2000.
13. Pesta M, Holubec L, Jr., Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J and Cerny R: Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Anticancer Res 25: 3387-3391, 2005.
14. Offenberg H, Brunner N, Mansilla F, Orntoft Torben F and Birkenkamp-Demtroder K: TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles. Mol Oncol 2: 233-240, 2008.
15. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W and Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1: 899-906, 1995.
16. Islekel H, Oktay G, Terzi C, Canda AE, Fuzun M and Kupelioglu A: Matrix metalloproteinase-9-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem Funct 25: 433-441, 2007.
17. Pesta M, Topolcan O, Holubec L Jr., Rupert K, Cerna M, Holubec LS, Treska V, Finek J and Cerny R: Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. Anticancer Res 27: 1863-1867, 2007.
18. Chirco R, Liu XW, Jung KK and Kim HR: Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 25: 99-113, 2006. (Pubitemid 43723986)
19. Sutnar A, Pesta M, Liska V, Treska V, Skalicky T, Kormunda S, Topolcan O, Cerny R and Holubec L Jr: Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases. Tumour Biol 28: 247-252, 2007.
20. Kahlert C, Bandapalli OR, Schirmacher P, Weitz J and Brand K: Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 28: 1459-1465, 2008. (Pubitemid 351892917)
21. Brand K, Baker AH, Perez-Canto A, Possling A, Sacharjat M, Geheeb M and Arnold W: Treatment of colorectal liver metastases by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 60: 5723-5730, 2000.
22. Kopitz C, Gerg M, Bandapalli OR, Ister D, Pennington CJ, Hauser S, Flechsig C, Krell HW, Antolovic D, Brew K, Nagase H, Stangl M, von Weyhern CW, Brucher BL, Brand K, Coussens LM, Edwards DR and Kruger A: Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling. Cancer Res 67: 8615-8623, 2007.